Individual and Combined Effects of 2′-Fucosyllactose and Bifidobacterium longum subsp. infantis on the Gut Microbiota Composition of Piglets

被引:0
|
作者
Wang, Mei [1 ]
Monaco, Marcia H. [1 ]
Daniels, Victoria C. [2 ]
Hirvonen, Johanna [3 ]
Jensen, Henrik Max [4 ]
Ouwehand, Arthur C. [3 ]
Mukherjea, Ratna [5 ]
Christensen, Niels [4 ]
Lehtinen, Markus J. [3 ]
Hibberd, Ashley A. [6 ]
Dilger, Ryan N. [2 ,7 ]
Donovan, Sharon M. [1 ,2 ]
机构
[1] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA
[2] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA
[3] IFF Hlth & Biosci, Kantvik, Finland
[4] IFF R&D Enabling Technol, Adv Analyt, Brabrand, Denmark
[5] IFF Hlth & Biosci, St Louis, MO USA
[6] IFF Hlth & Biosci, Madison, WI USA
[7] Univ Illinois, Dept Anim Sci, Urbana, IL USA
来源
JOURNAL OF NUTRITION | 2025年 / 155卷 / 02期
关键词
gut microbiota; short-chain fatty acids; human milk oligosaccharides; 2'-fucosyllactose; Bifidobacterium longum subsp. infantis; HUMAN-MILK OLIGOSACCHARIDES; CHAIN FATTY-ACIDS; FECAL MICROBIOTA; FED FORMULA; BREAST; NUTRITION; MODEL; LIFE; MULTICENTER; CONSUMPTION;
D O I
10.1016/j.tjnut.2024.12.022
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Human milk is a source of oligosaccharides that promote the growth of beneficial bacteria, including Bifidobacterium longum subsp. infantis, which can utilize human milk oligosaccharides. Objectives: To evaluate the individual and combined effects of 2 '-fucosyllactose (2 '-FL), B. infantis Bi-26 (Bi-26) on piglet gut microbiota composition, and short-chain fatty acid (SCFA) concentrations. Methods: Intact male pigs (n = 63) had ad libitum access to milk replacer without (control; CON) or with 1.0 g/L 2 '-FL (FL) from postnatal day 2 to 34/35. Pigs were further stratified to receive either 12% glycerol or 10(9) CFU/d Bi-26 in glycerol (BI and FLBI). Gut microbiota and SCFA concentrations were determined in ascending colon contents (AC) and rectal contents (RC) by 16S ribosomal ribonucleic acid gene sequencing and gas chromatography, respectively. Microbiota composition and functional profiles were analyzed using QIIME 2 and Phylogenetic Investigation of Communities by Reconstruction of Unobserved States-2 (PICRUSt2). Results: Supplementation of 2 '-FL increased valerate concentration in AC (P = 0.03) and tended to modulate the overall bacterial composition in RC (P = 0.06). Compared with CON, 2 '-FL alone increased the acetate concentration in AC (P < 0.05). The addition of Bi-26 decreased Shannon indices and reduced propionate and butyrate concentrations in AC (P < 0.05). Bi-26 alone affected the relative abundances of several bacterial amplicon sequence variants (ASVs) in AC and RC, including the ASVs identified as Phocaeicola (Bacteroides) vulgatus and Faecalibacterium prausnitzii. Additionally, 2 '-FL and Bi-26 individually increased the relative abundances of 9 PICRUSt2-predicted metabolic pathways related to fatty acid and lipid biosynthesis or carboxylate degradation/secondary metabolite degradation in the RC; however, these effects were negated, and the values were identical to the CON group when 2 '-FL and Bi-26 were supplemented together. Conclusions: 2 '-FL and Bi-26 added to milk replacer exerted distinct influences on gut bacterial composition and metabolic function, and 2 '-FL alone increased specific SCFA concentrations, demonstrating its prebiotic potential.
引用
收藏
页码:509 / 522
页数:14
相关论文
共 50 条
  • [41] Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
    Smita Awasthi
    Reason Wilken
    Forum Patel
    J. Bruce German
    David A. Mills
    Carlito B. Lebrilla
    Kyoungmi Kim
    Samara L. Freeman
    Jennifer T. Smilowitz
    April W. Armstrong
    Emanual Maverakis
    Trials, 17
  • [42] Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
    Ivashkin, Vladimir
    Fomin, Victor
    Moiseev, Sergey
    Brovko, Michail
    Maslennikov, Roman
    Ulyanin, Anatoly
    Sholomova, Victoria
    Vasilyeva, Maria
    Trush, Elizaveta
    Shifrin, Oleg
    Poluektova, Elena
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2023, 15 (03) : 460 - 468
  • [43] Identification of a prototype human gut Bifidobacterium longum subsp. longum strain based on comparative and functional genomic approaches
    Alessandri, Giulia
    Fontana, Federico
    Tarracchini, Chiara
    Rizzo, Sonia Mirjam
    Bianchi, Massimiliano G.
    Taurino, Giuseppe
    Chiu, Martina
    Lugli, Gabriele Andrea
    Mancabelli, Leonardo
    Argentini, Chiara
    Longhi, Giulia
    Anzalone, Rosaria
    Viappiani, Alice
    Milani, Christian
    Turroni, Francesca
    Bussolati, Ovidio
    van Sinderen, Douwe
    Ventura, Marco
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [44] Highly conserved bifidobacteria in the human gut: Bifidobacterium longum subsp. longum as a potential modulator of elderly innate immunity
    Longhi, G.
    Lugli, G. A.
    Bianchi, M. G.
    Rizzo, S. M.
    Tarracchini, C.
    Mancabelli, L.
    Vergna, L. M.
    Alessandri, G.
    Fontana, F.
    Taurino, G.
    Chiu, M.
    Milani, C.
    Van Sinderen, D.
    Bussolati, O.
    Ventura, M.
    Turroni, F.
    BENEFICIAL MICROBES, 2024, 15 (03) : 241 - 258
  • [45] Probiotic Bifidobacterium longum subsp. infantis 35624 in a Non-patient Population with a History of Abdominal Discomfort and Bloating
    Ringel, Yehuda
    Ringel-Kulka, Tamar
    McKean, Linda
    Ramsey, David
    Gibb, Roger
    McRorie, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S503 - S503
  • [46] Microencapsulated Bifidobacterium longum subsp infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats
    Rodes, Laetitia
    Saha, Shyamali
    Tomaro-Duchesneau, Catherine
    Prakash, Satya
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [47] Influence of 2'-Fucosyllactose and Bifidobacterium longum Subspecies infantis Supplementation on Cognitive and Structural Brain Development in Young Pigs
    Sutkus, Loretta T.
    Joung, Sangyun
    Hirvonen, Johanna
    Jensen, Henrik Max
    Ouwehand, Arthur C.
    Mukherjea, Ratna
    Donovan, Sharon M.
    Dilger, Ryan N.
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [48] Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota
    Dong, Yao
    Wu, Zhiyi
    Gai, Zhonghui
    Han, Mei
    JOURNAL OF APPLIED MICROBIOLOGY, 2023, 134 (11)
  • [49] Bifidobacterium longum subsp. infantis FJS']JSYZ1M3 ameliorates DSS-induced colitis by maintaining the intestinal barrier, regulating inflammatory cytokines, and modifying gut microbiota
    Li, Mingjie
    Ding, Jiuhong
    Stanton, Catherine
    Ross, R. Paul
    Zhao, Jianxin
    Yang, Bo
    Chen, Wei
    FOOD & FUNCTION, 2023, 14 (01) : 354 - 368
  • [50] Research Progress on the molecular mechanism of the Utilization of Human Milk Oligosaccharides in Bifidobacterium longum subsp. infantis and Its probiotic effect
    Chen Y.
    Li Q.
    Li Y.
    Su Q.
    Guo H.
    Duan B.
    Meng X.
    Shipin Kexue/Food Science, 2024, 45 (09): : 243 - 251